Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice

European Journal of Pharmacology(2025)10.1016/j.ejphar.2025.178132Source: DataRank Database

Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice is a research paper published in European Journal of Pharmacology (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 1.07)OA: closedTopics (31)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Samaneh Goorani ORCID,Anna Atamanchuk,Wojciech K. Jankiewicz ORCID,Michael M. Yeboah ORCID,Scott D. Barnett ORCID

Live enrichment

PubMed:40946955 OpenAlex:https://openalex.org/W4414149792

Juvenile Diabetes Research Foundation Canada

Grant: 2-SRA-2022-1210-S- B

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK103616

National Institute of Environmental Health Sciences

Grant: P42 ES004699

National Institute of Environmental Health Sciences

Grant: R35 ES030443-01

National Center for Advancing Translational Sciences

Grant: UL1TR003107

Welch Foundation

Grant: I-0011

NIDDK NIH HHS

Grant: R01 DK103616

NIEHS NIH HHS

Grant: R35 ES030443

NIMH NIH HHS

Grant: T32 MH018399

Arkansas Research Alliance

Arkansas Biosciences Institute

National Institutes of Health

FWCI

1.07

Citation Percentile

0.8%

Citation Trend

2026

closedLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

publisherhttps://api.elsevier.com/content/article/PII:S0014299925008866?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0014299925008866?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ejphar.2025.178132

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40946955

Fields of Study

Eicosanoids and Hypertension PharmacologyHormonal Regulation and HypertensionNitric Oxide and Endothelin EffectsMedicine

MeSH Terms

AlbuminuriaAnimalsDisease Models, AnimalEnzyme InhibitorsEpoxide HydrolasesGlomerulosclerosis, Focal SegmentalKidney GlomerulusMaleMembrane ProteinsPhenylurea CompoundsPiperidinesSolubilityMiceCyclooxygenase 2Cyclooxygenase 2 Inhibitors

Keywords

AlbuminuriaFocal segmental glomerulosclerosisKidneyPodocyteEpoxide hydrolase 2GlomerulosclerosisGlomerulonephritisRenal glomerulusMulti-target DrugsGlomerular InjuryLow Nephron NumberEpoxy Lipids